Posted in | News

Dow Deny Discussions About Leveraged Buyout

Reiterating comments made earlier today by Andrew Liveris, chairman and CEO of The Dow Chemical Company, the Company said that its Board of Directors fully supports Dow's management team and its plan to continue enhancing value for all shareholders through the execution of its strategy. The Company has had no discussion about a leveraged buyout.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.